協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/01/15 | 1,092 | 1,098 | 1,080 | 1,098 | +22 | +2% | 1,069,000 |
| 2014/01/14 | 1,097 | 1,100 | 1,074 | 1,076 | -51 | -4.5% | 1,669,000 |
| 2014/01/10 | 1,103 | 1,131 | 1,102 | 1,127 | +9 | +0.8% | 3,246,000 |
| 2014/01/09 | 1,120 | 1,136 | 1,112 | 1,118 | -20 | -1.8% | 1,249,000 |
| 2014/01/08 | 1,120 | 1,139 | 1,111 | 1,138 | +14 | +1.2% | 870,000 |
| 2014/01/07 | 1,128 | 1,142 | 1,123 | 1,124 | -5 | -0.4% | 1,046,000 |
| 2014/01/06 | 1,132 | 1,149 | 1,121 | 1,129 | -30 | -2.6% | 1,388,000 |
| 2013/12/30 | 1,154 | 1,159 | 1,135 | 1,159 | +16 | +1.4% | 769,000 |
| 2013/12/27 | 1,151 | 1,151 | 1,130 | 1,143 | +1 | +0.1% | 755,000 |
| 2013/12/26 | 1,138 | 1,149 | 1,131 | 1,142 | -1 | -0.1% | 780,000 |
| 2013/12/25 | 1,133 | 1,148 | 1,133 | 1,143 | -4 | -0.3% | 886,000 |
| 2013/12/24 | 1,158 | 1,160 | 1,144 | 1,147 | -5 | -0.4% | 935,000 |
| 2013/12/20 | 1,154 | 1,165 | 1,144 | 1,152 | -2 | -0.2% | 1,233,000 |
| 2013/12/19 | 1,155 | 1,164 | 1,149 | 1,154 | +7 | +0.6% | 1,295,000 |
| 2013/12/18 | 1,121 | 1,149 | 1,121 | 1,147 | +21 | +1.9% | 1,117,000 |
| 2013/12/17 | 1,122 | 1,129 | 1,116 | 1,126 | +10 | +0.9% | 705,000 |
| 2013/12/16 | 1,140 | 1,146 | 1,115 | 1,116 | -18 | -1.6% | 586,000 |
| 2013/12/13 | 1,131 | 1,146 | 1,123 | 1,134 | ±0 | ±0% | 3,156,000 |
| 2013/12/12 | 1,140 | 1,146 | 1,124 | 1,134 | -18 | -1.6% | 1,002,000 |
| 2013/12/11 | 1,155 | 1,162 | 1,146 | 1,152 | -14 | -1.2% | 683,000 |
| 2013/12/10 | 1,165 | 1,174 | 1,158 | 1,166 | -9 | -0.8% | 571,000 |
| 2013/12/09 | 1,185 | 1,185 | 1,165 | 1,175 | +31 | +2.7% | 908,000 |
| 2013/12/06 | 1,130 | 1,146 | 1,129 | 1,144 | -2 | -0.2% | 1,066,000 |
| 2013/12/05 | 1,155 | 1,167 | 1,144 | 1,146 | -22 | -1.9% | 881,000 |
| 2013/12/04 | 1,177 | 1,185 | 1,162 | 1,168 | -24 | -2% | 1,381,000 |
| 2013/12/03 | 1,199 | 1,199 | 1,190 | 1,192 | +3 | +0.3% | 1,238,000 |
| 2013/12/02 | 1,196 | 1,200 | 1,180 | 1,189 | -4 | -0.3% | 847,000 |
| 2013/11/29 | 1,166 | 1,195 | 1,166 | 1,193 | +8 | +0.7% | 1,850,000 |
| 2013/11/28 | 1,169 | 1,186 | 1,165 | 1,185 | +18 | +1.5% | 969,000 |
| 2013/11/27 | 1,155 | 1,167 | 1,153 | 1,167 | +13 | +1.1% | 745,000 |
| 2013/11/26 | 1,165 | 1,171 | 1,153 | 1,154 | -25 | -2.1% | 1,412,000 |
| 2013/11/25 | 1,163 | 1,180 | 1,150 | 1,179 | +28 | +2.4% | 1,386,000 |
| 2013/11/22 | 1,152 | 1,155 | 1,141 | 1,151 | +6 | +0.5% | 1,569,000 |
| 2013/11/21 | 1,130 | 1,145 | 1,120 | 1,145 | +21 | +1.9% | 1,649,000 |
| 2013/11/20 | 1,120 | 1,128 | 1,112 | 1,124 | +16 | +1.4% | 1,837,000 |
| 2013/11/19 | 1,100 | 1,124 | 1,089 | 1,108 | -12 | -1.1% | 1,161,000 |
| 2013/11/18 | 1,120 | 1,124 | 1,110 | 1,120 | +4 | +0.4% | 774,000 |
| 2013/11/15 | 1,117 | 1,118 | 1,099 | 1,116 | +16 | +1.5% | 1,008,000 |
| 2013/11/14 | 1,091 | 1,112 | 1,084 | 1,100 | +8 | +0.7% | 1,173,000 |
| 2013/11/13 | 1,079 | 1,098 | 1,070 | 1,092 | +5 | +0.5% | 1,439,000 |
| 2013/11/12 | 1,062 | 1,088 | 1,057 | 1,087 | +24 | +2.3% | 1,035,000 |
| 2013/11/11 | 1,060 | 1,066 | 1,043 | 1,063 | +17 | +1.6% | 896,000 |
| 2013/11/08 | 1,043 | 1,053 | 1,042 | 1,046 | -14 | -1.3% | 734,000 |
| 2013/11/07 | 1,058 | 1,066 | 1,058 | 1,060 | +1 | +0.1% | 640,000 |
| 2013/11/06 | 1,042 | 1,065 | 1,039 | 1,059 | +12 | +1.1% | 731,000 |
| 2013/11/05 | 1,065 | 1,071 | 1,041 | 1,047 | -10 | -0.9% | 980,000 |
| 2013/11/01 | 1,079 | 1,080 | 1,051 | 1,057 | -26 | -2.4% | 1,092,000 |
| 2013/10/31 | 1,061 | 1,088 | 1,061 | 1,083 | +33 | +3.1% | 1,880,000 |
| 2013/10/30 | 1,050 | 1,056 | 1,043 | 1,050 | +5 | +0.5% | 1,215,000 |
| 2013/10/29 | 1,035 | 1,049 | 1,033 | 1,045 | +3 | +0.3% | 723,000 |
2651～
2700
件表示中 / 3580件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 256,900円 | +11.3% | -5.4% | 2.26% | 19.77倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 塩野義 | 214,900円 | +5.7% | +3.9% | 2.67% | 10.69倍 | 1.41倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 495,700円 | +1.7% | -2.9% | 3.23% | 32.52倍 | 1.71倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 180,900円 | -3.5% | -50.2% | 4.42% | 14.65倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
| ロート | 273,600円 | +18.2% | +4.2% | 1.21% | 19.39倍 | 2.47倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム
